CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.1.1.Top investment pockets
3.1.2.Top winning strategies
3.2.Porter’s five forces analysis
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Prevalence of cancer
3.3.1.2.Increase in adoption of cell culture technique
3.3.1.3.Increase in research funding
3.3.2.Restraints
3.3.2.1.High capital investment
3.3.2.2.Lack of infrastructure for cell-based research
3.3.3.Opportunity
3.3.3.1.Expected rise in demand for advanced technologies
3.3.4.Impact analysis
3.4.Market share analysis (South Korea culture media market, 2019)
3.5.Impact analysis of COVID-19 on the cell culture market
CHAPTER 4:SOUTH KOREA CELL CULTURE MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Consumables
4.2.1.Market size and forecast
4.2.1.1.Sera
4.2.2.Market size and forecast
4.2.2.1.Media
4.2.3.Market size and forecast
4.2.3.1.Reagents
4.2.4.Market size and forecast
4.2.4.1.Bioreactor accessories
4.2.5.Market size and forecast
4.3.Instruments
4.3.1.Market size and forecast
4.3.1.1.Bioreactors
4.3.2.Market size and forecast
4.3.2.1.Cell culture vessels
4.3.3.Market size and forecast
4.3.3.1.Cell culture storage equipment
4.3.4.Market size and forecast
4.3.4.1.Cell culture supporting instruments
4.3.5.Market size and forecast
CHAPTER 5:SOUTH KOREA CELL CULTURE MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Stem cell technology
5.2.1.Market size and forecast
5.3.Cancer research
5.3.1.Market size and forecast
5.4.Drug screening and development
5.4.1.Market size and forecast
5.5.Tissue engineering & regenerative medicine
5.5.1.Market size and forecast
5.6.Others
5.6.1.Market size and forecast
CHAPTER 6:SOUTH KOREA CELL CULTURE MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Research institutes
6.2.1.Market size and forecast
6.3.Pharmaceutical & biotechnology companies
6.3.1.Market size and forecast
6.4.Others
6.4.1.Market size and forecast
CHAPTER 7:COMPANY PROFILES
7.1.AVANTOR, INC. (VWR INTERNATIONAL, LLC)
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.2.BIO-RAD LABORATORIES INC.
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments
7.3.CORNING INCORPORATED
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.DANAHER CORPORATION (CYTIVA)
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.FUJIFILM HOLDINGS CORPORATION (FUJIFILM IRVINE SCIENTIFIC, INC.)
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.MERCK KGAA
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.6.6.Key strategic moves and developments
7.7.MILTENYI BIOTEC B.V. & CO. KG
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Key strategic moves and developments
7.8.SARTORIUS AG
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments
7.9.STEMCELL TECHNOLOGIES INC.
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Key strategic moves and developments
7.10.THERMO FISHER SCIENTIFIC, INC.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key strategic moves and developments
TABLE 01.SOUTH KOREA CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 02.SOUTH KOREA CELL CULTURE MARKET, BY CONSUMABLES, 2019-2027 ($MILLION)
TABLE 03.SOUTH KOREA CELL CULTURE MARKET, BY INSTRUMENTS, 2019-2027 ($MILLION)
TABLE 04.SOUTH KOREA CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 05.SOUTH KOREA CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 06.AVANTOR: COMPANY SNAPSHOT
TABLE 07.AVANTOR: OPERATING SEGMENTS
TABLE 08.AVANTOR: PRODUCT PORTFOLIO
TABLE 09.BIO-RAD: COMPANY SNAPSHOT
TABLE 10.BIO-RAD: OPERATING SEGMENTS
TABLE 11.BIO-RAD: PRODUCT PORTFOLIO
TABLE 12.CORNING: COMPANY SNAPSHOT
TABLE 13.CORNING: OPERATING SEGMENT
TABLE 14.CORNING: PRODUCT PORTFOLIO
TABLE 15.CORNING: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 16.DANAHER: COMPANY SNAPSHOT
TABLE 17.DANAHER: OPERATING SEGMENTS
TABLE 18.DANAHER: PRODUCT PORTFOLIO
TABLE 19.DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 20.FUJIFILM: COMPANY SNAPSHOT
TABLE 21.FUJIFILM: OPERATING SEGMENTS
TABLE 22.FUJIFILM: PRODUCT PORTFOLIO
TABLE 23.MERCK: COMPANY SNAPSHOT
TABLE 24.MERCK: OPERATING SEGMENTS
TABLE 25.MERCK: PRODUCT PORTFOLIO
TABLE 26.MERCK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 27.MILTENYI BIOTEC: COMPANY SNAPSHOT
TABLE 28.MILTENYI BIOTEC: OPERATING SEGMENT
TABLE 29.MILTENYI BIOTEC: PRODUCT PORTFOLIO
TABLE 30.MILTENYI BIOTEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 31.SARTORIUS: COMPANY SNAPSHOT
TABLE 32.SARTORIUS: OPERATING BUSINESS SEGMENTS
TABLE 33.SARTORIUS: PRODUCT PORTFOLIO
TABLE 34.SARTORIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 35.STEMCELL: COMPANY SNAPSHOT
TABLE 36.STEMCELL: OPERATING SEGMENT
TABLE 37.STEMCELL: PRODUCT PORTFOLIO
TABLE 38.STEMCELL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 39.THERMO FISHER: COMPANY SNAPSHOT
TABLE 40.THERMO FISHER.: OPERATING SEGMENTS
TABLE 41.THERMO FISHER.: PRODUCT PORTFOLIO
TABLE 42.THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.SOUTH KOREA CELL CULTURE MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021 (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIER
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.MODERATE INTENSITY OF RIVALRY
FIGURE 10.LOW THREAT OF NEW ENTRANT
FIGURE 11.IMPACT ANALYSIS
FIGURE 12.MARKET SHARE ANALYSIS (SOUTH KOREA CULTURE MEDIA MARKET, 2019)
FIGURE 13.SOUTH KOREA CELL CULTURE MARKET FOR SERA, 2019-2027 ($MILLION)
FIGURE 14.SOUTH KOREA CELL CULTURE MARKET FOR MEDIA, 2019-2027 ($MILLION)
FIGURE 15.SOUTH KOREA CELL CULTURE MARKET FOR REAGENTS, 2019-2027 ($MILLION)
FIGURE 16.SOUTH KOREA CELL CULTURE MARKET FOR BIOREACTOR ACCESSORIES, 2019-2027 ($MILLION)
FIGURE 17.SOUTH KOREA CELL CULTURE MARKET FOR BIOREACTORS, 2019-2027 ($MILLION)
FIGURE 18.SOUTH KOREA CELL CULTURE MARKET FOR CELL CULTURE VESSELS, 2019-2027 ($MILLION)
FIGURE 19.SOUTH KOREA CELL CULTURE MARKET FOR CELL CULTURE STORAGE EQUIPMENT, 2019-2027 ($MILLION)
FIGURE 20.SOUTH KOREA CELL CULTURE MARKET FOR CELL CULTURE SUPPORTING INSTRUMENTS,
2019-2027 ($MILLION)
FIGURE 21.SOUTH KOREA CELL CULTURE MARKET FOR STEM CELL TECHNOLOGY, 2019-2027 ($MILLION)
FIGURE 22.SOUTH KOREA CELL CULTURE MARKET FOR CANCER RESEARCH, 2019-2027 ($MILLION)
FIGURE 23.SOUTH KOREA CELL CULTURE MARKET FOR DRUG SCREENING AND DEVELOPMENT, 2019-2027 ($MILLION)
FIGURE 24.SOUTH KOREA CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, 2019-2027 ($MILLION)
FIGURE 25.SOUTH KOREA CELL CULTURE MARKET FOR OTHERS, 2019-2027 ($MILLION)
FIGURE 26.SOUTH KOREA CELL CULTURE MARKET FOR RESEARCH INSTITUTES, 2019-2027 ($MILLION)
FIGURE 27.SOUTH KOREA CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 ($MILLION)
FIGURE 28.SOUTH KOREA CELL CULTURE MARKET FOR OTHERS, 2019-2027 ($MILLION)
FIGURE 29.AVANTOR: NET SALES, 2017–2019 ($MILLION)
FIGURE 30.AVANTOR: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 31.AVANTOR: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 32.BIO-RAD: NET SALES, 2017–2019 ($MILLION)
FIGURE 33.BIO-RAD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 34.BIO-RAD: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 35.CORNING: NET SALES, 2017–2019 ($MILLION)
FIGURE 36.CORNING: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 37.CORNING: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 38.DANAHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 39.DANAHER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 40.DANAHER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 41.FUJIFILM: NET SALES, 2017–2019 ($MILLION)
FIGURE 42.FUJIFILM: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 43.FUJIFILM: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 44.MERCK: NET SALES, 2017–2019 ($MILLION)
FIGURE 45.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 46.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 47.SARTORIUS: NET SALES, 2017–2019 ($MILLION)
FIGURE 48.SARTORIUS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 49.SARTORIUS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 50.THERMO FISHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 51.THERMO FISHER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 52.THERMO FISHER: REVENUE SHARE, BY REGION, 2019 (%)